Dr Matthew Parker, PhD candidate and rheumatologist at University of Sydney published on ‘multiple serum biomarkers associate with mortality and ILD progression in systemic sclerosis’ (Parker et al., Rheumatology 2024).
Access the article here.
Read a New CRE-PF Publication
Posted on: Tuesday 21st May 2024